SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial

Basu, J; Nikoletou, D; Miles, C; MacLachlan, H; Parry-Williams, G; Tilby-Jones, F; Bulleros, P; Fanton, Z; Baker, C; Purcell, S; et al. Basu, J; Nikoletou, D; Miles, C; MacLachlan, H; Parry-Williams, G; Tilby-Jones, F; Bulleros, P; Fanton, Z; Baker, C; Purcell, S; Lech, C; Chapman, T; Sage, P; Wahid, S; Sheikh, N; Jayakumar, S; Malhotra, A; Keteepe-Arachi, T; Gray, B; Finocchiaro, G; Carr-White, G; Behr, E; Tome, M; O'Driscoll, J; Chis Ster, D; Sharma, S; Papadakis, M (2025) High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial. European Heart Journal. ISSN 0195-668X https://doi.org/10.1093/eurheartj/ehae919
SGUL Authors: Nikoletou, Dimitra Finocchiaro, Gherardo Behr, Elijah Raphael Sharma, Sanjay Papadakis, Michael Chis Ster, Delizia Irina Tome, Maria Teresa

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB)
[img] PDF (Supplementary data) Supplemental Material
Download (5MB)

Abstract

Background and Aims The feasibility and impact of high intensity exercise programmes in patients with hypertrophic cardiomyopathy (HCM) are unknown. This study was conducted to determine the feasibility of a high intensity exercise programme and explore safety and efficacy outcomes in patients with HCM. Methods Participants were randomized to a 12-week supervised exercise programme (n = 40) in addition to usual care, or usual care alone (n = 40). All participants underwent assessment at baseline and 12 weeks. The exercise group was re-evaluated 6 months post-programme. Feasibility was assessed by (i) recruitment, adherence, and retention rates; (ii) staffing ratios; (iii) logistics; and (iv) acceptability of the intervention. The primary exploratory safety outcome was a composite of arrhythmia-related events. Exploratory secondary outcomes included changes in (i) cardiorespiratory fitness; (ii) cardiovascular risk factors; and (iii) quality of life, anxiety, and depression scores. Results Overall, 67 (84%) participants completed the study (n = 34 and n = 33 in the exercise and usual care groups, respectively). Reasons for non-adherence included travel, work, and family commitments. Resource provision complied with national cardiac rehabilitation standards. There was no difference between groups for the exploratory safety outcome (P = .99). At 12 weeks, the exercise group had a greater increase in peak oxygen consumption (VO2) [+4.1 mL/kg/min, 95% confidence interval (CI) 1.1, 7.1] and VO2 at anaerobic threshold (+2.3 mL/kg/min, 95% CI 0.4, 4.1), lower systolic blood pressure (−7.3 mmHg, 95% CI −11.7, −2.8) and body mass index (−0.8 kg/m2, 95% CI −1.1, −0.4), and greater improvement in hospital anxiety (−3, 95% CI −4.3, −1.7) and depression (−1.7, 95% CI −2.9, −0.5) scores, compared to the usual care group. Most exercise gains dissipated at 6 months. Conclusions A high intensity exercise programme is feasible in patients with HCM, with apparent cardiovascular and psychological benefits, and no increase in arrhythmias. A large-scale study is required to substantiate findings and assess long-term safety of high intensity exercise in HCM.

Item Type: Article
Additional Information: © The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Cardiovascular & Genomics Research Institute
Academic Structure > Cardiovascular & Genomics Research Institute > Clinical Cardiology
Academic Structure > Infection and Immunity Research Institute (INII)
Academic Structure > Institute of Medical, Biomedical and Allied Health Education (IMBE)
Academic Structure > Institute of Medical, Biomedical and Allied Health Education (IMBE) > Centre for Allied Health
Journal or Publication Title: European Heart Journal
ISSN: 0195-668X
Dates:
DateEvent
3 March 2025Published Online
17 December 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDCardiac Risk in the YoungUNSPECIFIED
URI: https://openaccess.sgul.ac.uk/id/eprint/117037
Publisher's version: https://doi.org/10.1093/eurheartj/ehae919

Actions (login required)

Edit Item Edit Item